Evidence map›Paper›PMID 33531882›Full record

ArticleContrast media & molecular imaging2021

Predictive Ki-67 Proliferation Index of Cervical Squamous Cell Carcinoma Based on IVIM-DWI Combined with Texture Features.

Cuiping Li, Mingxue Zheng, Xiaomin Zheng, Xin Fang, Jiangning Dong, Chuanbin Wang, Tingting Wang

Abstract read
In one paragraph

Article in Contrast media & molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cuiping LiDepartment of Radiology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.ORCID 0000-0002-3067-1943
Mingxue ZhengGraduate school, Bengbu Medical College, Bengbu 233030, Anhui Province, China.ORCID 0000-0002-9159-761X
Xiaomin ZhengDepartment of Radiation Oncology, Anhui Provincial Hospital Affiliated To Anhui Medical University, Hefei 230001, China.ORCID 0000-0002-9813-2321
Xin FangDepartment of Radiology, First Affiliated Hospital, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei 230031, China.ORCID 0000-0003-0097-7682
Jiangning DongDepartment of Radiology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.ORCID 0000-0003-3883-5698
Chuanbin WangDepartment of Radiology, First Affiliated Hospital, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei 230031, China.ORCID 0000-0002-4743-360X
Tingting WangDepartment of Radiology, First Affiliated Hospital, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei 230031, China.ORCID 0000-0002-6103-8374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aims to determine whether IVIM-DWI combined with texture features based on preoperative IVIM-DWI could be used to predict the Ki-67 PI, which is a widely used cell proliferation biomarker in CSCC. Methods: A total of 70 patients were included. Among these patients, 16 patients were divided into the Ki-67 PI <50% group and 54 patients were divided into the Ki-67 PI ≥50% group based on the retrospective surgical evaluation. All patients were examined using a 3.0T MRI unit with one standard protocol, including an IVIM-DWI sequence with 10 Results: The Conclusions: Texture analysis on IVIM-DWI and its parameters was helpful for predicting Ki-67 PI and may provide a noninvasive method to investigate important imaging biomarkers for CSCC.

Indexed as

Diffusion Magnetic Resonance ImagingAdultAgedCarcinoma, Squamous CellCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansKi-67 AntigenMiddle AgedPelvic BonesPreoperative PeriodUterine Cervical NeoplasmsKi-67 Antigen

Identifiers

PMID33531882
PMCPMC7826202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.